Condition
Manic-Depressive Psychosis
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (2)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00454883Completed
Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.
NCT04643210Not ApplicableUnknown
Management of my Bipolarity Intervention in Bipolar Disorder Patients
NCT00422214Phase 3Completed
Phase III/Seroquel SR Bipolar Depression Monotherapy - US
NCT00422123Phase 3Completed
Phase 3 /Seroquel SR Acute Mania Monotherapy - US
Showing all 4 trials